UNSPSC 85815312: Introduction of other anti-infective into respiratory tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other anti-infective into respiratory tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F329

UNSPSC 85815312 Introduction of other anti-infective into respiratory tract, percutaneous approach is a Commodity code that names a specific clinical procedure — yet the recent state and local opportunities tagged under it bear no relationship to this medical intervention. Instead, the tagged solicitations span occupational health services, telehealth platforms, emergency medical services, cancer registry administration, wellness programs, and behavioral health delivery. The code shows no material recent activity aligned with its nominal scope.

The mismatch signals that this Commodity code either is misapplied by issuing bodies in the state and local procurement ecosystem, or sees so little relevant activity that procurement officers resort to inexact categorization. Across the opportunities listed, issuing bodies include health authorities, counties, cities, school districts, and public health agencies, but none are seeking respiratory anti-infective procedures or related clinical supplies. The geographic spread spans California, Georgia, Nevada, Colorado, Florida, Texas, Arizona, New York, Minnesota, Oregon, Illinois, and the District of Columbia, though this distribution reflects the breadth of unrelated health and human services activity, not coherent demand for the code's stated commodity. No recent opportunity in the source is pursuing the procurement of anti-infective agents for respiratory tract administration. Unless your firm has established channels into state and local respiratory therapy or infection control procurement, this code merits close monitoring to confirm whether issuing bodies will eventually tag respiratory therapeutics correctly, or whether the current mislabeling reflects a systemic categorization error in the UNSPSC implementation across state and local systems.